Search Results - "Akadam-Teker B"

Role of JAK2 V617F in Myeloproliferative Neoplasms: From Mutation to Manifestation: A Review.

Authors: Dhar, Oindrila Bhaumik, Somdatta Sharma, Abhishek et al.

Source: Nigerian Medical Journal. May/Jun2026, Vol. 67 Issue 3, p806-822. 17p.

PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical Experiments.

Authors: Skoczyńska, Anna Ołdakowska, Monika Dobosz, Agnieszka et al.

Source: Biomolecules (2218-273X). Jul2024, Vol. 14 Issue 7, p786. 34p.

The Impact of ASXL1 Gene Mutations on Clinical Course and Prognosis in Myeloproliferative Neoplasms.

Authors: Uslu, Neslihan Hancer, Veysel Sabri Kucukkaya, Reyhan Diz

Source: European Archives of Medical Research. Sep2025, Vol. 41 Issue 3, p154-162. 9p.

Molecular landscape of non-driver genes in myeloproliferative neoplasms through 333 cancer genes panel: Insights to reveal in Pakistan.

Authors: Rashid, Munazza Ahmed, Rifat Zubair Usmani, Muhammad Asad et al.

Source: BMC Medical Genomics. 8/4/2025, Vol. 18 Issue 1, p1-13. 13p.

The clinical characteristics of Janus Kinase 2-positive myeloproliferative neoplasms in Saudi Arabia.

Authors: AlShomar, Ahmad^1,2 (AUTHOR) a.alshomar@qu.edu.sa

Source: Iraqi Journal of Hematology. Jul-Dec2025, Vol. 14 Issue 2, p205-210. 6p.

Evaluation of Hormonal Factors in Acne Vulgaris and the Course of Acne Vulgaris Treatment with Contraceptive-Based Therapies in Young Adult Women.

Authors: Borzyszkowska, Dominika Niedzielska, Mirela Kozłowski, Mateusz et al.

Source: Cells (2073-4409). Dec2022, Vol. 11 Issue 24, p4078. 16p.

Prognosis and risk factors for ASXL1 mutations in patients with newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.

Authors: Liqing Yang Xiaoyu Wei Yuping Gong

Source: Cancer Medicine. Jan2024, Vol. 13 Issue 1, p1-13. 13p.

Utility of Immunohistochemistry Markers CK19, Gal-3, HBME-1 and Their Combinations for Differential Diagnosis of Thyroid Diseases.

Authors: Dağlar Aday, Aynur Demir, Hale Öztürk, Tülin

Source: Indian Journal of Surgery. Oct2023, Vol. 85 Issue 5, p1203-1211. 9p.

Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms.

Alternate Title: Philadelphia-Negatif Kronik Myeloproliferatif Neoplazide JAK2V617F Allel Yükünün Klinik Önemi.

Authors: Yönal-Hindilerden, İpek Şahin, Ezgi Hindilerden, Fehmi et al.

Source: Turkish Journal of Hematology. 2023, Vol. 40 Issue 3, p174-182. 9p.

Evaluation of the Relationship between Janus Kinase 2 Mutational Burden and Clinical Findings in Adult Myeloproliferative Neoplasm Patients.

Authors: Kahraman, Cigdem Yuce Sincan, Gulden Tatar, Abdulgani

Source: Medical Bulletin of Haseki / Haseki Tip Bulteni. Jan2022, Vol. 60 Issue 1, p26-32. 7p.

The impact of JAK2V617F mutation on Philadelphia-negative myeloproliferative neoplasms.

Authors: ŞAHİN, Ezgi YÖNAL-HİNDİLERDEN, İpek HİNDİLERDEN, Fehmi et al.

Source: Turkish Journal of Medical Sciences. 2022, Vol. 52 Issue 1, p150-165. 16p.

Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis.

Transliterated Title: Esansiyel Trombositemi ve Primer Miyelofibroziste JAK2V617F Mutasyonunun Fenotipik Etkileri.

Authors: Yönal İ Dağlar-Aday A Akadam-Teker B et al.

Source: Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2016 Jun 05; Vol. 33 (2), pp. 94-101. Date of Electronic Publication: 2015 Apr 27.

Publication Type: Journal Article

Journal Info: Publisher: Galenos Yayinevi Country of Publication: Turkey NLM ID: 9606065 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1308-5263 (Electronic) Linking ISSN: 13007777 NLM ISO Abbreviation: Turk J Haematol Subsets: MEDLINE

Concomitant T315I and E459K mutations in chronic myeloid leukemia: A case report.

Authors: Zhou, Xin Huang, Shi-Ting Shan, Ning-Ning

Source: Oncology Letters. Sep2025, Vol. 30 Issue 3, pN.PAG-N.PAG. 1p.

Molecular mechanism underlying the hypolipidemic effect of Shanmei Capsule based on network pharmacology and molecular docking.

Authors: Wang, Qian Du, Lijing Hong, Jiana et al.

Source: Technology & Health Care. Feb2021, p1-18. 18p.

The Pro12Ala Polymorphism in the Peroxisome Proliferator-Activated Receptor Gamma-2 Gene (PPARc2) Is Associated with Increased Risk of Coronary Artery Disease: A Meta-Analysis.

Authors: Zhijun Wu Yuqing Lou Wei Jin et al.

Source: PLoS ONE. Dec2012, Vol. 7 Issue 12, p1-14. 14p.

Effects of the Variants of Activin Receptor-like Kinase-1 and 2 on the Lipid Profile of Patients with Coronary Heart Disease.

Alternate Title: Aktivin-benzeri Kinaz Reseptörleri-1 ve 2 Varyantlarının Koroner Arter Hastalarında Lipid Profiline olan Etkilerinin Araştırılması.

Authors: Teker, Ayşegül Başak Akadam Teker, Erhan Aydoğan, Hülya Yılmaz

Source: Istanbul Medical Journal. 2020, Vol. 21 Issue 5, p391-396. 6p.

Relationship between Lipid Phenotypes, Overweight, Lipid Lowering Drug Response and KIF6 and HMG-CoA Genotypes in a Subset of the Brisighella Heart Study Population.

Authors: Angelini, Sabrina Rosticci, Martina Massimo, Gianmichele et al.

Source: International Journal of Molecular Sciences. Jan2018, Vol. 19 Issue 1, p49. 17p. 7 Charts, 3 Graphs.

Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review.

Authors: Paththinige, C. S. Sirisena, N. D. Dissanayake, V. H. W.

Source: Lipids in Health & Disease. 6/2/2017, Vol. 16, p1-22. 22p. 2 Color Photographs, 1 Diagram.

TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms.

Alternate Title: Kronik Miyeloproliferatif Neoplazi Tanılı Türk Hastalarda TET2, ASXL1, IDH1 ve IDH2 Tek Nükleotid Polimorfizmleri.

Authors: Soyer, Nur Kaymaz, Burçin Tezcanlı Özkan, Melda Cömert et al.

Source: Turkish Journal of Hematology. 2017, Vol. 34 Issue 2, p174-178. 5p.

ASXL1 and JAK2V617F gene mutation screening in Iranian patients with chronic myeloid leukemia.

Authors: Valikhani, Amir Poopak, Behzad Ferdowsi, Shirin et al.

Source: Asia Pacific Journal of Clinical Oncology. Apr2017, Vol. 13 Issue 2, pe41-e47. 7p.